Keywords: astellas, fiscal, 06/07, first-half, net, sales, rise
Astellas' fiscal 06/07 first-half net sales rise 5%
Article | 20 November 2006
Japanese drug major Astellas says that its net sales for the six-month period ending September 30, 2006, reached 447.92 billion yen ($3.8 billion), a 5% ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
